![](/img/cover-not-exists.png)
Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer
Holmes, F.A., O’Shaughnessy, J.A., Vukelja, S., Jones, S.E., Shogan, J., Savin, M., Glaspy, J., Moore, M., Meza, L., Wiznitzer, I., Neumann, T.A., Hill, L.R., Liang, B.C.Volume:
20
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2002.20.3.727
Date:
February, 2002
File:
PDF, 61 KB
english, 2002